Toggle navigation
Home
Search
Services
Blog
Contact
About
Voice Driven Pathology Management Systems
Grasso, Michael A.
Segue Corporation, Laurel, MD, United States
Search 8 grants from Michael Grasso
Search grants from Segue Corporation
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Interrogating functional and molecular properties of PAX7+ putative skeletal muscle stem/progenitor cells derived from human iPSCs of healthy donors and Duchenne muscular dystrophy patients
Depression and accelerated brain aging: A PET imaging study
Structure and Function of the Hepatitis C Virus Genome
Clozapine Effects on Glutamate Transmission and Dopamine
Marc U*Star at Suny Old Westbury
Recently added grants:
The role of AXL-ABL axis in Barrett's carcinogenesis
Project 1: Determining and Exploiting Mechanisms of AR-Mediated Suppression of Cell Proliferation and Survival
Project 2: Mechanisms Driving AR Full Length and Splice Variant Activities and Antagonist Resistance
Project 4: Identification of Essential Genes Underlying AR Activity in Antagonist-Resistant CRPC
Core A: Administrative Core
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44RR007978-02A2
Application #
2040059
Study Section
Special Emphasis Panel (ZRG7-SSS-9 (02))
Project Start
1992-09-30
Project End
1998-09-08
Budget Start
1996-09-30
Budget End
1997-09-29
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Segue Corporation
Department
Type
DUNS #
City
Laurel
State
MD
Country
United States
Zip Code
20723
Related projects
NIH 1997
R44 RR
Voice Driven Pathology Management Systems
Grasso, Michael A. / Segue Corporation
NIH 1996
R44 RR
Voice Driven Pathology Management Systems
Grasso, Michael A. / Segue Corporation
Comments
Be the first to comment on Michael Grasso's grant